{"id":16421,"date":"2013-03-22T11:30:00","date_gmt":"2013-03-22T10:30:00","guid":{"rendered":"http:\/\/www.fedaiisf.it\/aifa-intervista-alla-dr-ssa-marra-sul-consumo-dei-farmaci-equivalenti\/"},"modified":"2013-03-22T11:30:00","modified_gmt":"2013-03-22T10:30:00","slug":"aifa-intervista-alla-dr-ssa-marra-sul-consumo-dei-farmaci-equivalenti","status":"publish","type":"post","link":"https:\/\/www.fedaiisf.it\/en\/aifa-intervista-alla-dr-ssa-marra-sul-consumo-dei-farmaci-equivalenti\/","title":{"rendered":"AIFA. Interview with Dr. Marra on the consumption of generic medicines"},"content":{"rendered":"

Dr. Anna Rosa Marra, director of the Evaluation and Authorization office, speaking on TG5, explored the theme of the consumption of generic drugs in Italy.
When asked by the journalist on the reasons why the consumption of generic medicines is still low, Dr. Marra clarified "that it is above all a cultural problem<\/span><\/em>\u201d.
The mistrust in the use of generic drugs is not supported by scientific evidence<\/span><\/em> \u2013 underlines Anna Rosa Marra \u2013 Generic drugs are medicines that are the same as others, with the same safety tests, equivalent, indeed bioequivalent, to designer medicines.<\/p>\n

<\/span><\/em><\/span><\/p>\n

AIFA \u2013 22 March 2013<\/p>\n

<\/span><\/em><\/p>\n

<\/p>\n

 <\/p>\n

<\/span><\/em><\/p>\n

Go to video<\/font><\/span><\/em><\/a><\/p>\n

<\/span><\/p>\n

In-depth documents regarding generic medicines<\/font><\/span><\/em><\/a><\/p>\n

<\/span><\/p>\n

<\/p>\n

 <\/p>\n

<\/span><\/p>\n

Prescription for active principle<\/span><\/b><\/a><\/p>\n

<\/span><\/i><\/p>\n

Update to 03\/15\/2013 of the tables with the class A drug list to allow all Operators to prescribe the active ingredient<\/font><\/a><\/p>\n

<\/span><\/b><\/p>\n

La dott.ssa Anna Rosa Marra, direttore dell’ufficio Valutazione e Autorizzazione, intervenuta al TG5, approfondisce la tematica del consumo dei farmaci generici in Italia. Alla richiesta del giornalista sulle motivazioni per le quali il consumo dei medicinali generici è ancora poco elevato, la dott.ssa Marra chiarisce “che si tratta di un problema soprattutto culturale”. La diffidenza …<\/p>","protected":false},"author":1,"featured_media":9846,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[90],"tags":[],"class_list":["post-16421","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-fedaiisf-archivio-storico"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/16421","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/comments?post=16421"}],"version-history":[{"count":0,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/16421\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media\/9846"}],"wp:attachment":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media?parent=16421"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/categories?post=16421"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/tags?post=16421"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}